A Meta‐Analysis of Band Reporting Probabilities for North American Waterfowl

2019 ◽  
Vol 84 (3) ◽  
pp. 534-541 ◽  
Author(s):  
Todd W. Arnold ◽  
Ray T. Alisauskas ◽  
James S. Sedinger
Keyword(s):  
2016 ◽  
Vol 23 (3) ◽  
pp. 1065-1074 ◽  
Author(s):  
Dylan Craven ◽  
Madhav P. Thakur ◽  
Erin K. Cameron ◽  
Lee E. Frelich ◽  
Robin Beauséjour ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0168613 ◽  
Author(s):  
Lisa A. Waddell ◽  
Judy Greig ◽  
Mariola Mascarenhas ◽  
Shannon Harding ◽  
Robbin Lindsay ◽  
...  

2015 ◽  
Vol 282 (1804) ◽  
pp. 20142903 ◽  
Author(s):  
David R. Roberts ◽  
Andreas Hamann

North American tree species, subspecies and genetic varieties have primarily evolved in a landscape of extensive continental ice and restricted temperate climate environments. Here, we reconstruct the refugial history of western North American trees since the last glacial maximum using species distribution models, validated against 3571 palaeoecological records. We investigate how modern subspecies structure and genetic diversity corresponds to modelled glacial refugia, based on a meta-analysis of allelic richness and expected heterozygosity for 473 populations of 22 tree species. We find that species with strong genetic differentiation into subspecies had widespread and large glacial refugia, whereas species with restricted refugia show no differentiation among populations and little genetic diversity, despite being common over a wide range of environments today. In addition, a strong relationship between allelic richness and the size of modelled glacial refugia ( r 2 = 0.55) suggest that population bottlenecks during glacial periods had a pronounced effect on the presence of rare alleles.


2017 ◽  
Vol 141 (3) ◽  
pp. 423-430 ◽  
Author(s):  
Xulei Liu ◽  
Michael Kinzler ◽  
Jiangfan Yuan ◽  
Guozhong He ◽  
Lanjing Zhang

Context.— Little is known regarding the reporting quality of meta-analyses in diagnostic pathology. Objective.— To compare reporting quality of meta-analyses in diagnostic pathology and medicine and to examine factors associated with reporting quality of diagnostic pathology meta-analyses. Design.— Meta-analyses were identified in 12 major diagnostic pathology journals without specifying years and 4 major medicine journals in 2006 and 2011 using PubMed. Reporting quality of meta-analyses was evaluated using the 27-item checklist of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement published in 2009. A higher PRISMA score indicates higher reporting quality. Results.— Forty-one diagnostic pathology meta-analyses and 118 medicine meta-analyses were included. Overall, reporting quality of meta-analyses in diagnostic pathology was lower than that in medicine (median [interquartile range] = 22 [15, 25] versus 27 [23, 28], P < .001). Compared with medicine meta-analyses, diagnostic pathology meta-analyses less likely reported 23 of the 27 items (85.2%) on the PRISMA checklist, but more likely reported the data items. Higher reporting quality of diagnostic pathology meta-analyses was associated with recent publication years (later than 2009 versus 2009 or earlier, P = .002) and non–North American first authors (versus North American, P = .001), but not journal publisher's location (P = .11). Interestingly, reporting quality was not associated with adjusted citation ratio for meta-analyses in either diagnostic pathology or medicine (P = .40 and P = .09, respectively). Conclusions.— Meta-analyses in diagnostic pathology had lower reporting quality than those in medicine. Reporting quality of diagnostic pathology meta-analyses is linked to publication year and first author's location, but not to journal publisher's location or article's adjusted citation ratios. More research and education on meta-analysis methodology may improve the reporting quality of diagnostic pathology meta-analyses.


2019 ◽  
Vol 51 (12) ◽  
pp. 785-791 ◽  
Author(s):  
Qing Chen ◽  
Man Guo ◽  
Xiumei Ma ◽  
Yueli Pu ◽  
Yang Long ◽  
...  

AbstractTo conduct a retrospective systematic review and meta-analysis of studies investigating the fracture risk among adherence versus non-adherence patients to treatment for osteoporosis. Cohort studies involving adherence to specifically Teriparatide treatment and the risk of fracture, published from inception to June 10 2019, were identified through PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus database of Systematic Reviews. Five eligible cohort studies were included for analysis. Overall, adherence, compared with nonadherence, had a significant 28% reduction in the risk of all fractures, an 49% reduction in the risk of hip fracture and an 26% reduction in the risk of non-vertebral fracture. Subgroup analyses showed that treatment compliant North American patients had a lower incidence of fracture than treatment compliant Asian patients. The effect size associated with adherence showed no difference with non-adherence when the analysis was limited to a small sample size (<10 000 patients). The findings of this retrospective review indicate that high compliance of Teriparatide treatment result in a decreased risk of fracture, particularly in North American treatment adherence, compared with Asian treatment adherence. Improvement of treatment adherence in patients with osteoporosis should be considered through various means in clinical practice.


2011 ◽  
Vol 13 (4) ◽  
pp. 301-307 ◽  
Author(s):  
Sarita Koushik ◽  
Sally Hewat ◽  
Rosalee C Shenker ◽  
Mark Jones ◽  
Mark Onslow

Sign in / Sign up

Export Citation Format

Share Document